nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS1—Ifosfamide—germ cell cancer	0.113	0.161	CbGbCtD
Naproxen—UGT1A1—Etoposide—germ cell cancer	0.106	0.152	CbGbCtD
Naproxen—CYP2C8—Ifosfamide—germ cell cancer	0.0651	0.0932	CbGbCtD
Naproxen—PTGS2—Cisplatin—germ cell cancer	0.065	0.093	CbGbCtD
Naproxen—PTGS2—Etoposide—germ cell cancer	0.0639	0.0914	CbGbCtD
Naproxen—PTGS1—Etoposide—germ cell cancer	0.0539	0.0771	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—germ cell cancer	0.0515	0.0737	CbGbCtD
Naproxen—CYP2C9—Ifosfamide—germ cell cancer	0.0454	0.065	CbGbCtD
Naproxen—SLC22A6—Methotrexate—germ cell cancer	0.0313	0.0447	CbGbCtD
Naproxen—CYP2C8—Etoposide—germ cell cancer	0.0311	0.0445	CbGbCtD
Naproxen—ALB—Methotrexate—germ cell cancer	0.0266	0.0381	CbGbCtD
Naproxen—CYP1A2—Etoposide—germ cell cancer	0.0241	0.0345	CbGbCtD
Naproxen—CYP2C9—Cisplatin—germ cell cancer	0.0221	0.0316	CbGbCtD
Naproxen—CYP2C9—cardial valve—germ cell cancer	0.00875	0.148	CbGeAlD
Naproxen—UGT1A1—urine—germ cell cancer	0.00449	0.0757	CbGeAlD
Naproxen—AKR1C3—Podofilox—Etoposide—germ cell cancer	0.0034	0.539	CbGdCrCtD
Naproxen—AKR1C3—Vincristine—Vinblastine—germ cell cancer	0.00291	0.461	CbGdCrCtD
Naproxen—CYP1A2—urine—germ cell cancer	0.00199	0.0335	CbGeAlD
Naproxen—CYP2C9—urine—germ cell cancer	0.00189	0.0318	CbGeAlD
Naproxen—AKR1C3—trigeminal ganglion—germ cell cancer	0.00163	0.0275	CbGeAlD
Naproxen—PTGS2—appendage—germ cell cancer	0.0016	0.027	CbGeAlD
Naproxen—PTGS2—skin epidermis—germ cell cancer	0.00133	0.0225	CbGeAlD
Naproxen—AKR1C3—decidua—germ cell cancer	0.00121	0.0205	CbGeAlD
Naproxen—PTGS1—ganglion—germ cell cancer	0.00117	0.0198	CbGeAlD
Naproxen—AKR1C3—uterus—germ cell cancer	0.00106	0.0179	CbGeAlD
Naproxen—AKR1C3—pituitary gland—germ cell cancer	0.00104	0.0176	CbGeAlD
Naproxen—PTGS1—endothelium—germ cell cancer	0.00101	0.0171	CbGeAlD
Naproxen—AKR1C3—medulla oblongata—germ cell cancer	0.00101	0.017	CbGeAlD
Naproxen—PTGS2—endothelium—germ cell cancer	0.000968	0.0163	CbGeAlD
Naproxen—PTGS1—blood vessel—germ cell cancer	0.000934	0.0157	CbGeAlD
Naproxen—AKR1C3—adrenal gland—germ cell cancer	0.000932	0.0157	CbGeAlD
Naproxen—AKR1C3—midbrain—germ cell cancer	0.00092	0.0155	CbGeAlD
Naproxen—AKR1C3—bone marrow—germ cell cancer	0.000901	0.0152	CbGeAlD
Naproxen—AKR1C3—spinal cord—germ cell cancer	0.000897	0.0151	CbGeAlD
Naproxen—PTGS2—blood vessel—germ cell cancer	0.000893	0.015	CbGeAlD
Naproxen—UGT2B7—endocrine gland—germ cell cancer	0.000876	0.0148	CbGeAlD
Naproxen—AKR1C3—female gonad—germ cell cancer	0.000869	0.0146	CbGeAlD
Naproxen—UGT2B7—testis—germ cell cancer	0.000835	0.0141	CbGeAlD
Naproxen—SLCO1A2—telencephalon—germ cell cancer	0.0008	0.0135	CbGeAlD
Naproxen—AKR1C3—testis—germ cell cancer	0.00077	0.013	CbGeAlD
Naproxen—UGT1A1—endocrine gland—germ cell cancer	0.000745	0.0126	CbGeAlD
Naproxen—AKR1C3—cerebellum—germ cell cancer	0.000711	0.012	CbGeAlD
Naproxen—SLCO1A2—medulla oblongata—germ cell cancer	0.000628	0.0106	CbGeAlD
Naproxen—ALB—adrenal gland—germ cell cancer	0.000578	0.00975	CbGeAlD
Naproxen—AKR1C3—brain—germ cell cancer	0.000578	0.00974	CbGeAlD
Naproxen—SLC22A6—brain—germ cell cancer	0.000576	0.0097	CbGeAlD
Naproxen—SLCO1A2—midbrain—germ cell cancer	0.000574	0.00968	CbGeAlD
Naproxen—SLCO1A2—spinal cord—germ cell cancer	0.00056	0.00944	CbGeAlD
Naproxen—AKR1C3—lymph node—germ cell cancer	0.000558	0.00941	CbGeAlD
Naproxen—PTGS2—trigeminal ganglion—germ cell cancer	0.000551	0.0093	CbGeAlD
Naproxen—PTGS2—embryo—germ cell cancer	0.000533	0.00898	CbGeAlD
Naproxen—SLCO1A2—endocrine gland—germ cell cancer	0.000504	0.0085	CbGeAlD
Naproxen—SLCO1A2—head—germ cell cancer	0.000498	0.00839	CbGeAlD
Naproxen—SLCO1A2—testis—germ cell cancer	0.000481	0.00811	CbGeAlD
Naproxen—ALB—testis—germ cell cancer	0.000478	0.00806	CbGeAlD
Naproxen—CYP2C8—pituitary gland—germ cell cancer	0.000455	0.00767	CbGeAlD
Naproxen—PTGS1—telencephalon—germ cell cancer	0.000453	0.00764	CbGeAlD
Naproxen—SLCO1A2—cerebellum—germ cell cancer	0.000444	0.00749	CbGeAlD
Naproxen—PTGS2—telencephalon—germ cell cancer	0.000433	0.0073	CbGeAlD
Naproxen—PTGS1—skin of body—germ cell cancer	0.000432	0.00729	CbGeAlD
Naproxen—PTGS2—skin of body—germ cell cancer	0.000413	0.00697	CbGeAlD
Naproxen—PTGS1—uterus—germ cell cancer	0.000376	0.00633	CbGeAlD
Naproxen—PTGS1—pituitary gland—germ cell cancer	0.000369	0.00622	CbGeAlD
Naproxen—SLCO1A2—brain—germ cell cancer	0.000361	0.00608	CbGeAlD
Naproxen—PTGS2—uterus—germ cell cancer	0.000359	0.00605	CbGeAlD
Naproxen—ALB—brain—germ cell cancer	0.000359	0.00605	CbGeAlD
Naproxen—PTGS2—pituitary gland—germ cell cancer	0.000353	0.00594	CbGeAlD
Naproxen—CYP2C8—endocrine gland—germ cell cancer	0.000352	0.00594	CbGeAlD
Naproxen—ALB—lymph node—germ cell cancer	0.000347	0.00584	CbGeAlD
Naproxen—PTGS2—medulla oblongata—germ cell cancer	0.00034	0.00574	CbGeAlD
Naproxen—CYP2C8—testis—germ cell cancer	0.000336	0.00567	CbGeAlD
Naproxen—CYP1A2—endocrine gland—germ cell cancer	0.00033	0.00556	CbGeAlD
Naproxen—PTGS1—adrenal gland—germ cell cancer	0.00033	0.00556	CbGeAlD
Naproxen—PTGS1—spinal cord—germ cell cancer	0.000317	0.00535	CbGeAlD
Naproxen—PTGS2—adrenal gland—germ cell cancer	0.000315	0.00531	CbGeAlD
Naproxen—CYP2C9—endocrine gland—germ cell cancer	0.000313	0.00528	CbGeAlD
Naproxen—PTGS2—midbrain—germ cell cancer	0.000311	0.00524	CbGeAlD
Naproxen—PTGS1—female gonad—germ cell cancer	0.000307	0.00518	CbGeAlD
Naproxen—PTGS2—bone marrow—germ cell cancer	0.000305	0.00514	CbGeAlD
Naproxen—PTGS2—spinal cord—germ cell cancer	0.000303	0.00511	CbGeAlD
Naproxen—PTGS2—female gonad—germ cell cancer	0.000294	0.00495	CbGeAlD
Naproxen—PTGS1—endocrine gland—germ cell cancer	0.000286	0.00482	CbGeAlD
Naproxen—PTGS1—head—germ cell cancer	0.000282	0.00476	CbGeAlD
Naproxen—PTGS2—endocrine gland—germ cell cancer	0.000273	0.0046	CbGeAlD
Naproxen—PTGS1—testis—germ cell cancer	0.000273	0.00459	CbGeAlD
Naproxen—PTGS2—head—germ cell cancer	0.00027	0.00455	CbGeAlD
Naproxen—Eye disorder—Etoposide—germ cell cancer	0.000267	0.00114	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000266	0.00113	CcSEcCtD
Naproxen—Cardiac disorder—Etoposide—germ cell cancer	0.000265	0.00113	CcSEcCtD
Naproxen—Discomfort—Ifosfamide—germ cell cancer	0.000265	0.00113	CcSEcCtD
Naproxen—Hypersensitivity—Vinblastine—germ cell cancer	0.000263	0.00112	CcSEcCtD
Naproxen—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000262	0.00112	CcSEcCtD
Naproxen—Decreased appetite—Bleomycin—germ cell cancer	0.000262	0.00111	CcSEcCtD
Naproxen—Visual disturbance—Methotrexate—germ cell cancer	0.000261	0.00111	CcSEcCtD
Naproxen—Muscle spasms—Cisplatin—germ cell cancer	0.000261	0.00111	CcSEcCtD
Naproxen—Angiopathy—Etoposide—germ cell cancer	0.000259	0.0011	CcSEcCtD
Naproxen—Confusional state—Ifosfamide—germ cell cancer	0.000259	0.0011	CcSEcCtD
Naproxen—Immune system disorder—Etoposide—germ cell cancer	0.000258	0.0011	CcSEcCtD
Naproxen—Mediastinal disorder—Etoposide—germ cell cancer	0.000258	0.0011	CcSEcCtD
Naproxen—Pain—Bleomycin—germ cell cancer	0.000257	0.00109	CcSEcCtD
Naproxen—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000257	0.00109	CcSEcCtD
Naproxen—Oedema—Ifosfamide—germ cell cancer	0.000257	0.00109	CcSEcCtD
Naproxen—Chills—Etoposide—germ cell cancer	0.000257	0.00109	CcSEcCtD
Naproxen—Vision blurred—Cisplatin—germ cell cancer	0.000256	0.00109	CcSEcCtD
Naproxen—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000256	0.00109	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000256	0.00109	CcSEcCtD
Naproxen—Asthenia—Vinblastine—germ cell cancer	0.000256	0.00109	CcSEcCtD
Naproxen—Infection—Ifosfamide—germ cell cancer	0.000256	0.00109	CcSEcCtD
Naproxen—Tremor—Cisplatin—germ cell cancer	0.000255	0.00108	CcSEcCtD
Naproxen—Alopecia—Etoposide—germ cell cancer	0.000253	0.00107	CcSEcCtD
Naproxen—Nervous system disorder—Ifosfamide—germ cell cancer	0.000252	0.00107	CcSEcCtD
Naproxen—CYP2C8—brain—germ cell cancer	0.000252	0.00425	CbGeAlD
Naproxen—Ill-defined disorder—Cisplatin—germ cell cancer	0.000252	0.00107	CcSEcCtD
Naproxen—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000252	0.00107	CcSEcCtD
Naproxen—Anaemia—Cisplatin—germ cell cancer	0.000251	0.00107	CcSEcCtD
Naproxen—Skin disorder—Ifosfamide—germ cell cancer	0.00025	0.00106	CcSEcCtD
Naproxen—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000249	0.00106	CcSEcCtD
Naproxen—Feeling abnormal—Bleomycin—germ cell cancer	0.000248	0.00105	CcSEcCtD
Naproxen—Osteoarthritis—Methotrexate—germ cell cancer	0.000248	0.00105	CcSEcCtD
Naproxen—Anorexia—Ifosfamide—germ cell cancer	0.000245	0.00104	CcSEcCtD
Naproxen—Malaise—Cisplatin—germ cell cancer	0.000245	0.00104	CcSEcCtD
Naproxen—Decreased appetite—Dactinomycin—germ cell cancer	0.000244	0.00104	CcSEcCtD
Naproxen—Diarrhoea—Vinblastine—germ cell cancer	0.000244	0.00104	CcSEcCtD
Naproxen—Leukopenia—Cisplatin—germ cell cancer	0.000243	0.00103	CcSEcCtD
Naproxen—Fatigue—Dactinomycin—germ cell cancer	0.000242	0.00103	CcSEcCtD
Naproxen—PTGS2—cerebellum—germ cell cancer	0.000241	0.00406	CbGeAlD
Naproxen—Hypotension—Ifosfamide—germ cell cancer	0.00024	0.00102	CcSEcCtD
Naproxen—Pain—Dactinomycin—germ cell cancer	0.00024	0.00102	CcSEcCtD
Naproxen—Muscle spasms—Etoposide—germ cell cancer	0.000239	0.00102	CcSEcCtD
Naproxen—Urticaria—Bleomycin—germ cell cancer	0.000239	0.00102	CcSEcCtD
Naproxen—Body temperature increased—Bleomycin—germ cell cancer	0.000238	0.00101	CcSEcCtD
Naproxen—Dizziness—Vinblastine—germ cell cancer	0.000236	0.001	CcSEcCtD
Naproxen—Convulsion—Cisplatin—germ cell cancer	0.000235	0.001	CcSEcCtD
Naproxen—Mood swings—Methotrexate—germ cell cancer	0.000235	0.000998	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000234	0.000997	CcSEcCtD
Naproxen—Myalgia—Cisplatin—germ cell cancer	0.000231	0.000984	CcSEcCtD
Naproxen—Feeling abnormal—Dactinomycin—germ cell cancer	0.000231	0.000984	CcSEcCtD
Naproxen—Paraesthesia—Ifosfamide—germ cell cancer	0.000231	0.000982	CcSEcCtD
Naproxen—Ill-defined disorder—Etoposide—germ cell cancer	0.000231	0.000982	CcSEcCtD
Naproxen—Anxiety—Cisplatin—germ cell cancer	0.000231	0.00098	CcSEcCtD
Naproxen—Anaemia—Etoposide—germ cell cancer	0.00023	0.000979	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00023	0.000977	CcSEcCtD
Naproxen—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00023	0.000976	CcSEcCtD
Naproxen—Dyspnoea—Ifosfamide—germ cell cancer	0.000229	0.000975	CcSEcCtD
Naproxen—Somnolence—Ifosfamide—germ cell cancer	0.000229	0.000973	CcSEcCtD
Naproxen—Liver function test abnormal—Methotrexate—germ cell cancer	0.000229	0.000972	CcSEcCtD
Naproxen—Discomfort—Cisplatin—germ cell cancer	0.000229	0.000972	CcSEcCtD
Naproxen—Vomiting—Vinblastine—germ cell cancer	0.000227	0.000964	CcSEcCtD
Naproxen—Malaise—Etoposide—germ cell cancer	0.000224	0.000955	CcSEcCtD
Naproxen—Breast disorder—Methotrexate—germ cell cancer	0.000224	0.000952	CcSEcCtD
Naproxen—Vertigo—Etoposide—germ cell cancer	0.000224	0.000951	CcSEcCtD
Naproxen—Decreased appetite—Ifosfamide—germ cell cancer	0.000224	0.000951	CcSEcCtD
Naproxen—Headache—Vinblastine—germ cell cancer	0.000223	0.00095	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000223	0.000948	CcSEcCtD
Naproxen—Leukopenia—Etoposide—germ cell cancer	0.000223	0.000948	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000222	0.000945	CcSEcCtD
Naproxen—Abdominal pain—Dactinomycin—germ cell cancer	0.000222	0.000944	CcSEcCtD
Naproxen—Body temperature increased—Dactinomycin—germ cell cancer	0.000222	0.000944	CcSEcCtD
Naproxen—Fatigue—Ifosfamide—germ cell cancer	0.000222	0.000943	CcSEcCtD
Naproxen—Oedema—Cisplatin—germ cell cancer	0.000222	0.000943	CcSEcCtD
Naproxen—Anaphylactic shock—Cisplatin—germ cell cancer	0.000222	0.000943	CcSEcCtD
Naproxen—Hypersensitivity—Bleomycin—germ cell cancer	0.000222	0.000943	CcSEcCtD
Naproxen—Infection—Cisplatin—germ cell cancer	0.00022	0.000937	CcSEcCtD
Naproxen—Pain—Ifosfamide—germ cell cancer	0.00022	0.000936	CcSEcCtD
Naproxen—Constipation—Ifosfamide—germ cell cancer	0.00022	0.000936	CcSEcCtD
Naproxen—Loss of consciousness—Etoposide—germ cell cancer	0.000219	0.000931	CcSEcCtD
Naproxen—Nervous system disorder—Cisplatin—germ cell cancer	0.000217	0.000925	CcSEcCtD
Naproxen—Cough—Etoposide—germ cell cancer	0.000217	0.000924	CcSEcCtD
Naproxen—Thrombocytopenia—Cisplatin—germ cell cancer	0.000217	0.000923	CcSEcCtD
Naproxen—Tachycardia—Cisplatin—germ cell cancer	0.000216	0.000921	CcSEcCtD
Naproxen—Asthenia—Bleomycin—germ cell cancer	0.000216	0.000918	CcSEcCtD
Naproxen—Convulsion—Etoposide—germ cell cancer	0.000216	0.000917	CcSEcCtD
Naproxen—Skin disorder—Cisplatin—germ cell cancer	0.000215	0.000916	CcSEcCtD
Naproxen—Hypertension—Etoposide—germ cell cancer	0.000215	0.000914	CcSEcCtD
Naproxen—Hyperhidrosis—Cisplatin—germ cell cancer	0.000214	0.000912	CcSEcCtD
Naproxen—Asthma—Methotrexate—germ cell cancer	0.000214	0.00091	CcSEcCtD
Naproxen—Pruritus—Bleomycin—germ cell cancer	0.000213	0.000906	CcSEcCtD
Naproxen—Feeling abnormal—Ifosfamide—germ cell cancer	0.000212	0.000902	CcSEcCtD
Naproxen—Chest pain—Etoposide—germ cell cancer	0.000212	0.000901	CcSEcCtD
Naproxen—Eosinophilia—Methotrexate—germ cell cancer	0.000212	0.000901	CcSEcCtD
Naproxen—Nausea—Vinblastine—germ cell cancer	0.000212	0.0009	CcSEcCtD
Naproxen—Anorexia—Cisplatin—germ cell cancer	0.000211	0.000899	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00021	0.000895	CcSEcCtD
Naproxen—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00021	0.000895	CcSEcCtD
Naproxen—Pancreatitis—Methotrexate—germ cell cancer	0.00021	0.000892	CcSEcCtD
Naproxen—Discomfort—Etoposide—germ cell cancer	0.000209	0.000891	CcSEcCtD
Naproxen—Hypotension—Cisplatin—germ cell cancer	0.000207	0.000881	CcSEcCtD
Naproxen—Hypersensitivity—Dactinomycin—germ cell cancer	0.000207	0.00088	CcSEcCtD
Naproxen—Abdominal discomfort—Methotrexate—germ cell cancer	0.000205	0.000873	CcSEcCtD
Naproxen—Confusional state—Etoposide—germ cell cancer	0.000205	0.000871	CcSEcCtD
Naproxen—PTGS1—brain—germ cell cancer	0.000204	0.00345	CbGeAlD
Naproxen—Urticaria—Ifosfamide—germ cell cancer	0.000204	0.000869	CcSEcCtD
Naproxen—Abdominal pain—Ifosfamide—germ cell cancer	0.000203	0.000865	CcSEcCtD
Naproxen—Body temperature increased—Ifosfamide—germ cell cancer	0.000203	0.000865	CcSEcCtD
Naproxen—Pancytopenia—Methotrexate—germ cell cancer	0.000203	0.000864	CcSEcCtD
Naproxen—Anaphylactic shock—Etoposide—germ cell cancer	0.000203	0.000864	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000202	0.000859	CcSEcCtD
Naproxen—Infection—Etoposide—germ cell cancer	0.000202	0.000858	CcSEcCtD
Naproxen—Asthenia—Dactinomycin—germ cell cancer	0.000201	0.000857	CcSEcCtD
Naproxen—Dysuria—Methotrexate—germ cell cancer	0.0002	0.000851	CcSEcCtD
Naproxen—Paraesthesia—Cisplatin—germ cell cancer	0.000199	0.000847	CcSEcCtD
Naproxen—Thrombocytopenia—Etoposide—germ cell cancer	0.000199	0.000846	CcSEcCtD
Naproxen—Tachycardia—Etoposide—germ cell cancer	0.000198	0.000843	CcSEcCtD
Naproxen—Dyspnoea—Cisplatin—germ cell cancer	0.000198	0.000841	CcSEcCtD
Naproxen—PTGS1—lymph node—germ cell cancer	0.000198	0.00333	CbGeAlD
Naproxen—Skin disorder—Etoposide—germ cell cancer	0.000197	0.000839	CcSEcCtD
Naproxen—Hyperhidrosis—Etoposide—germ cell cancer	0.000196	0.000835	CcSEcCtD
Naproxen—PTGS2—brain—germ cell cancer	0.000195	0.00329	CbGeAlD
Naproxen—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000195	0.000831	CcSEcCtD
Naproxen—Anorexia—Etoposide—germ cell cancer	0.000194	0.000824	CcSEcCtD
Naproxen—Decreased appetite—Cisplatin—germ cell cancer	0.000193	0.00082	CcSEcCtD
Naproxen—Diarrhoea—Dactinomycin—germ cell cancer	0.000192	0.000817	CcSEcCtD
Naproxen—Pneumonia—Methotrexate—germ cell cancer	0.000192	0.000816	CcSEcCtD
Naproxen—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000191	0.000814	CcSEcCtD
Naproxen—Vomiting—Bleomycin—germ cell cancer	0.000191	0.000814	CcSEcCtD
Naproxen—Drowsiness—Methotrexate—germ cell cancer	0.000191	0.000812	CcSEcCtD
Naproxen—Depression—Methotrexate—germ cell cancer	0.00019	0.000809	CcSEcCtD
Naproxen—Hypotension—Etoposide—germ cell cancer	0.00019	0.000807	CcSEcCtD
Naproxen—Rash—Bleomycin—germ cell cancer	0.00019	0.000807	CcSEcCtD
Naproxen—Pain—Cisplatin—germ cell cancer	0.00019	0.000807	CcSEcCtD
Naproxen—Dermatitis—Bleomycin—germ cell cancer	0.00019	0.000806	CcSEcCtD
Naproxen—Hypersensitivity—Ifosfamide—germ cell cancer	0.00019	0.000806	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000189	0.000805	CcSEcCtD
Naproxen—PTGS2—lymph node—germ cell cancer	0.000189	0.00318	CbGeAlD
Naproxen—Renal failure—Methotrexate—germ cell cancer	0.000188	0.000798	CcSEcCtD
Naproxen—Stomatitis—Methotrexate—germ cell cancer	0.000186	0.000791	CcSEcCtD
Naproxen—Conjunctivitis—Methotrexate—germ cell cancer	0.000185	0.000789	CcSEcCtD
Naproxen—Asthenia—Ifosfamide—germ cell cancer	0.000185	0.000785	CcSEcCtD
Naproxen—Sweating—Methotrexate—germ cell cancer	0.000183	0.000778	CcSEcCtD
Naproxen—Feeling abnormal—Cisplatin—germ cell cancer	0.000183	0.000777	CcSEcCtD
Naproxen—Paraesthesia—Etoposide—germ cell cancer	0.000182	0.000776	CcSEcCtD
Naproxen—Pruritus—Ifosfamide—germ cell cancer	0.000182	0.000774	CcSEcCtD
Naproxen—Haematuria—Methotrexate—germ cell cancer	0.000182	0.000774	CcSEcCtD
Naproxen—Dyspnoea—Etoposide—germ cell cancer	0.000181	0.00077	CcSEcCtD
Naproxen—Somnolence—Etoposide—germ cell cancer	0.000181	0.000768	CcSEcCtD
Naproxen—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00018	0.000767	CcSEcCtD
Naproxen—Epistaxis—Methotrexate—germ cell cancer	0.00018	0.000765	CcSEcCtD
Naproxen—Nausea—Bleomycin—germ cell cancer	0.000179	0.00076	CcSEcCtD
Naproxen—Vomiting—Dactinomycin—germ cell cancer	0.000178	0.000759	CcSEcCtD
Naproxen—Agranulocytosis—Methotrexate—germ cell cancer	0.000178	0.000757	CcSEcCtD
Naproxen—Rash—Dactinomycin—germ cell cancer	0.000177	0.000753	CcSEcCtD
Naproxen—Decreased appetite—Etoposide—germ cell cancer	0.000177	0.000751	CcSEcCtD
Naproxen—Diarrhoea—Ifosfamide—germ cell cancer	0.000176	0.000749	CcSEcCtD
Naproxen—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000175	0.000746	CcSEcCtD
Naproxen—Body temperature increased—Cisplatin—germ cell cancer	0.000175	0.000746	CcSEcCtD
Naproxen—Fatigue—Etoposide—germ cell cancer	0.000175	0.000745	CcSEcCtD
Naproxen—Constipation—Etoposide—germ cell cancer	0.000174	0.000739	CcSEcCtD
Naproxen—Pain—Etoposide—germ cell cancer	0.000174	0.000739	CcSEcCtD
Naproxen—Haemoglobin—Methotrexate—germ cell cancer	0.000172	0.000732	CcSEcCtD
Naproxen—Haemorrhage—Methotrexate—germ cell cancer	0.000171	0.000729	CcSEcCtD
Naproxen—Hepatitis—Methotrexate—germ cell cancer	0.000171	0.000729	CcSEcCtD
Naproxen—Dizziness—Ifosfamide—germ cell cancer	0.00017	0.000723	CcSEcCtD
Naproxen—Pharyngitis—Methotrexate—germ cell cancer	0.00017	0.000723	CcSEcCtD
Naproxen—Urinary tract disorder—Methotrexate—germ cell cancer	0.000169	0.000719	CcSEcCtD
Naproxen—Urethral disorder—Methotrexate—germ cell cancer	0.000168	0.000714	CcSEcCtD
Naproxen—Feeling abnormal—Etoposide—germ cell cancer	0.000167	0.000712	CcSEcCtD
Naproxen—Nausea—Dactinomycin—germ cell cancer	0.000167	0.000709	CcSEcCtD
Naproxen—Gastrointestinal pain—Etoposide—germ cell cancer	0.000166	0.000707	CcSEcCtD
Naproxen—Visual impairment—Methotrexate—germ cell cancer	0.000165	0.000702	CcSEcCtD
Naproxen—Vomiting—Ifosfamide—germ cell cancer	0.000164	0.000696	CcSEcCtD
Naproxen—Hypersensitivity—Cisplatin—germ cell cancer	0.000163	0.000695	CcSEcCtD
Naproxen—Rash—Ifosfamide—germ cell cancer	0.000162	0.00069	CcSEcCtD
Naproxen—Dermatitis—Ifosfamide—germ cell cancer	0.000162	0.000689	CcSEcCtD
Naproxen—Erythema multiforme—Methotrexate—germ cell cancer	0.000162	0.000689	CcSEcCtD
Naproxen—Urticaria—Etoposide—germ cell cancer	0.000161	0.000686	CcSEcCtD
Naproxen—Abdominal pain—Etoposide—germ cell cancer	0.000161	0.000683	CcSEcCtD
Naproxen—Body temperature increased—Etoposide—germ cell cancer	0.000161	0.000683	CcSEcCtD
Naproxen—Eye disorder—Methotrexate—germ cell cancer	0.00016	0.000681	CcSEcCtD
Naproxen—Tinnitus—Methotrexate—germ cell cancer	0.00016	0.000679	CcSEcCtD
Naproxen—Asthenia—Cisplatin—germ cell cancer	0.000159	0.000677	CcSEcCtD
Naproxen—Cardiac disorder—Methotrexate—germ cell cancer	0.000159	0.000676	CcSEcCtD
Naproxen—Angiopathy—Methotrexate—germ cell cancer	0.000155	0.000661	CcSEcCtD
Naproxen—Immune system disorder—Methotrexate—germ cell cancer	0.000155	0.000658	CcSEcCtD
Naproxen—Mediastinal disorder—Methotrexate—germ cell cancer	0.000154	0.000657	CcSEcCtD
Naproxen—Chills—Methotrexate—germ cell cancer	0.000154	0.000654	CcSEcCtD
Naproxen—Nausea—Ifosfamide—germ cell cancer	0.000153	0.00065	CcSEcCtD
Naproxen—Diarrhoea—Cisplatin—germ cell cancer	0.000152	0.000645	CcSEcCtD
Naproxen—Alopecia—Methotrexate—germ cell cancer	0.000151	0.000644	CcSEcCtD
Naproxen—Mental disorder—Methotrexate—germ cell cancer	0.00015	0.000638	CcSEcCtD
Naproxen—Hypersensitivity—Etoposide—germ cell cancer	0.00015	0.000637	CcSEcCtD
Naproxen—Erythema—Methotrexate—germ cell cancer	0.000149	0.000634	CcSEcCtD
Naproxen—Malnutrition—Methotrexate—germ cell cancer	0.000149	0.000634	CcSEcCtD
Naproxen—Asthenia—Etoposide—germ cell cancer	0.000146	0.00062	CcSEcCtD
Naproxen—Pruritus—Etoposide—germ cell cancer	0.000144	0.000611	CcSEcCtD
Naproxen—Vomiting—Cisplatin—germ cell cancer	0.000141	0.0006	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—germ cell cancer	0.000141	0.000598	CcSEcCtD
Naproxen—Rash—Cisplatin—germ cell cancer	0.00014	0.000595	CcSEcCtD
Naproxen—Dermatitis—Cisplatin—germ cell cancer	0.00014	0.000594	CcSEcCtD
Naproxen—Diarrhoea—Etoposide—germ cell cancer	0.000139	0.000591	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—germ cell cancer	0.000138	0.000588	CcSEcCtD
Naproxen—Anaemia—Methotrexate—germ cell cancer	0.000138	0.000586	CcSEcCtD
Naproxen—Malaise—Methotrexate—germ cell cancer	0.000134	0.000572	CcSEcCtD
Naproxen—Dizziness—Etoposide—germ cell cancer	0.000134	0.000571	CcSEcCtD
Naproxen—Vertigo—Methotrexate—germ cell cancer	0.000134	0.00057	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—germ cell cancer	0.000133	0.000568	CcSEcCtD
Naproxen—Nausea—Cisplatin—germ cell cancer	0.000132	0.00056	CcSEcCtD
Naproxen—Cough—Methotrexate—germ cell cancer	0.00013	0.000553	CcSEcCtD
Naproxen—Convulsion—Methotrexate—germ cell cancer	0.000129	0.000549	CcSEcCtD
Naproxen—Vomiting—Etoposide—germ cell cancer	0.000129	0.000549	CcSEcCtD
Naproxen—Rash—Etoposide—germ cell cancer	0.000128	0.000545	CcSEcCtD
Naproxen—Dermatitis—Etoposide—germ cell cancer	0.000128	0.000544	CcSEcCtD
Naproxen—Headache—Etoposide—germ cell cancer	0.000127	0.000541	CcSEcCtD
Naproxen—Chest pain—Methotrexate—germ cell cancer	0.000127	0.00054	CcSEcCtD
Naproxen—Myalgia—Methotrexate—germ cell cancer	0.000127	0.00054	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—germ cell cancer	0.000127	0.00054	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000126	0.000536	CcSEcCtD
Naproxen—Discomfort—Methotrexate—germ cell cancer	0.000125	0.000533	CcSEcCtD
Naproxen—Confusional state—Methotrexate—germ cell cancer	0.000123	0.000522	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—germ cell cancer	0.000122	0.000518	CcSEcCtD
Naproxen—Infection—Methotrexate—germ cell cancer	0.000121	0.000514	CcSEcCtD
Naproxen—Nausea—Etoposide—germ cell cancer	0.000121	0.000513	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—germ cell cancer	0.000119	0.000508	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—germ cell cancer	0.000119	0.000507	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—germ cell cancer	0.000118	0.000503	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—germ cell cancer	0.000118	0.0005	CcSEcCtD
Naproxen—Anorexia—Methotrexate—germ cell cancer	0.000116	0.000493	CcSEcCtD
Naproxen—Hypotension—Methotrexate—germ cell cancer	0.000114	0.000484	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000111	0.000472	CcSEcCtD
Naproxen—Insomnia—Methotrexate—germ cell cancer	0.00011	0.000468	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—germ cell cancer	0.000109	0.000465	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—germ cell cancer	0.000108	0.000461	CcSEcCtD
Naproxen—Somnolence—Methotrexate—germ cell cancer	0.000108	0.00046	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—germ cell cancer	0.000107	0.000456	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—germ cell cancer	0.000106	0.00045	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000105	0.000447	CcSEcCtD
Naproxen—Fatigue—Methotrexate—germ cell cancer	0.000105	0.000446	CcSEcCtD
Naproxen—Pain—Methotrexate—germ cell cancer	0.000104	0.000443	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—germ cell cancer	0.0001	0.000427	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—germ cell cancer	9.95e-05	0.000423	CcSEcCtD
Naproxen—Urticaria—Methotrexate—germ cell cancer	9.67e-05	0.000411	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—germ cell cancer	9.62e-05	0.000409	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—germ cell cancer	9.62e-05	0.000409	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—germ cell cancer	8.97e-05	0.000381	CcSEcCtD
Naproxen—Asthenia—Methotrexate—germ cell cancer	8.73e-05	0.000371	CcSEcCtD
Naproxen—Pruritus—Methotrexate—germ cell cancer	8.61e-05	0.000366	CcSEcCtD
Naproxen—Diarrhoea—Methotrexate—germ cell cancer	8.33e-05	0.000354	CcSEcCtD
Naproxen—Dizziness—Methotrexate—germ cell cancer	8.05e-05	0.000342	CcSEcCtD
Naproxen—Vomiting—Methotrexate—germ cell cancer	7.74e-05	0.000329	CcSEcCtD
Naproxen—Rash—Methotrexate—germ cell cancer	7.67e-05	0.000326	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—germ cell cancer	7.67e-05	0.000326	CcSEcCtD
Naproxen—Headache—Methotrexate—germ cell cancer	7.62e-05	0.000324	CcSEcCtD
Naproxen—Nausea—Methotrexate—germ cell cancer	7.23e-05	0.000307	CcSEcCtD
